News BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Real-time Estimate Tradegate Other stock markets 12:21:28 18/05/2024 am IST			5-day change	1st Jan Change
12.15 ^EUR	+2.97%		+2.59%	-4.03%

14/05	BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	CI
09/05	Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	15/05	BU
BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024	15/05	CI
Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up	09/05	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05	MT
BeiGene's Q1 Loss Narrows as Revenue Rises	08/05	MT
Earnings Flash (BGNE) BEIGENE Reports Q1 Revenue $752M	08/05	MT
BeiGene Reports First Quarter 2024 Financial Results and Business Updates	08/05	BU
BeiGene, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024	08/05	CI
Amgen Posts Higher 1Q Revenue, Swings to Loss	03/05	DJ
BeiGene : Financial Information - Form 8-K	26/04	PU
BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report	26/04	BU
Global Oncology Innovator BeiGene Highlights New Data across Hematology and Solid Tumor Portfolio at 2024 ASCO Annual Meeting	25/04	BU
Sector Update: Health Care Stocks Rise in Afternoon Trading	23/04	MT
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise	23/04	MT
BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment	23/04	DJ
Technology Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	23/04	MT
BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer	23/04	MT
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	23/04	BU
BeiGene, Ltd. Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer	23/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Summary

Filters